HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.

Abstract
Programmed electrical stimulation was performed in 12 patients with moderate to severe congestive heart failure and ventricular tachycardia (VT) to study possible arrhythmogenic properties of ibopamine, a new orally active dopamine agonist. Ibopamine induced no significant changes in spontaneous cycle length, PR, QRS, QTc, AH or HV intervals, and also right ventricular effective refractory periods were unaffected (for paced cycle lengths of 600 and 430 ms, respectively, using 1 extrastimulus: 287 +/- 16 ms at baseline vs 283 +/- 27 ms after ibopamine and 270 +/- 23 ms during the control study vs 262 +/- 19 ms after ibopamine). In 6 of the 8 patients with coronary artery disease but in none of the 4 patients with dilated cardiomyopathy, sustained VT was induced before and after ibopamine. Proarrhythmia was present in 1 patient, who became inducible after ibopamine. However, 1 patient had sustained VT only at baseline but not after ibopamine. The number of extrastimuli required for VT induction was equal (2.7 +/- 0.2 vs 2.7 +/- 0.2). Holter monitoring showed no changes in ventricular premature complexes, ventricular couplets and runs of VT after 1 week of ibopamine therapy. The signal-averaged electrocardiogram was abnormal in 11 and showed late potentials in 5 patients, but no changes occurred after ibopamine. During hemodynamic evaluation, increases in cardiac (32%) and stroke volume (34%) indexes were seen after administration of 100 mg of ibopamine, accompanied by a decrease in vascular resistance and filling pressures. Plasma norepinephrine decreased significantly after ibopamine (p = 0.02) but plasma epinephrine was unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsD J Van Veldhuisen, H J Crijns, A R Girbes, T J Tobé, A C Wiesfeld, K I Lie
JournalThe American journal of cardiology (Am J Cardiol) Vol. 68 Issue 11 Pg. 1194-202 (Nov 01 1991) ISSN: 0002-9149 [Print] United States
PMID1683146 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Catecholamines
  • Dopamine Agents
  • ibopamine
  • Deoxyepinephrine
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects)
  • Cardiac Pacing, Artificial
  • Catecholamines (blood)
  • Deoxyepinephrine (analogs & derivatives, therapeutic use)
  • Dopamine Agents (pharmacology)
  • Electrocardiography (drug effects)
  • Electrocardiography, Ambulatory
  • Female
  • Heart Failure (blood, complications, drug therapy, physiopathology)
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Stroke Volume (drug effects)
  • Tachycardia (complications, physiopathology)
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: